Neomed Labs Pacific Biomarkers PAIRimmune are now Nexelis
 
News, Events & Publications × clear filter

or filter by:

subscribe now

Press Release

Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Marburg – Germany and enters into a 5-year strategic agreement with GSK

20 Jan 2021 | Press Release

Laval, Quebec, and Marburg, Germany, January 20, 2021. Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider […]

read more

Nexelis, an Agile Approach to Bioanalysis

15 Oct 2020 | Press Release

read more

CEPI establishes global network of laboratories to centralise assessment of COVID-19 vaccine candidates

02 Oct 2020 | Press Release

Five laboratories initially selected to work together as part of centralised network to reliably assess and compare immunological responses generated […]

read more

Nexelis Acquires Integrated Bioanalytical CRO AIT Bioscience

July 22, 2020 | Press Release

Laval, Quebec, and Indianapolis, IN, July 22, 2020 – Nexelis, a portfolio company of Ampersand Capital Partners and a leading […]

read more

Nexelis to Acquire Specialty Immunogenicity and Immune-Oncology Testing Laboratory ImmunXperts

March 4, 2020 | Press Release

Laval, Quebec, and Gosselies, Belgium, March 04, 2020 – Nexelis, a portfolio company of Ampersand Capital Partners, and a leading […]

read more

1 2

back to top
contact us now

contact us

  • This field is for validation purposes and should be left unchanged.